IRIS
VANNI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.470
Totale 3.470
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 3.470
Totale 3.470
Salva come PNG Salva come JPEG
Città #
Genova 1.965
Rapallo 584
Genoa 474
Vado Ligure 436
Bordighera 11
Totale 3.470
Salva come PNG Salva come JPEG
Nome #
Efficacy of motesanib diphosphate in non-small-cell lung cancer. 149
Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine. 144
Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients 139
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma 132
Oral vinorelbine in the treatment of non-small-cell lung cancer. 121
Belagenpumatucel-L for the treatment of non-small cell lung cancer 116
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients 103
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 100
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 100
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors 98
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system 97
Understanding the checkpoint blockade in lung cancer immunotherapy 91
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin 90
Human leukocyte antigen-B (-Bw6/-Bw4 I 80, T 80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis 88
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 83
Next-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by ion torrent PGM™ platform 79
Current State of Target Treatment in BRAF Mutated Melanoma 75
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 73
Exosomes: a new horizon in lung cancer 73
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer 71
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 70
Vinflunine for the treatment of non-small cell lung cancer 70
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy 69
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 66
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 65
An improved method for HLA-B and -C supratyping 65
Whole-genome sequencing as standard practice for the analysis of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in a paediatric setting 63
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 61
Afatinib for the treatment of non-small cell lung cancer 58
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 56
Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma 55
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 54
Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: Report of a secondary anaplastic astrocytoma carrying the IDH1 mutation 53
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 53
Development and validation of a multiplex quantitative polymerase chain reaction assay for the detection of Mollicutes impurities in human cells, cultured under good manufacturing practice conditions, and following European Pharmacopoeia requirements and the International Conference on Harmonization guidelines 52
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 52
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer 48
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients 46
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma 44
Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments 44
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 43
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms 43
A sensible technique to detect mollicutes impurities in human cells cultured in GMP condition 43
Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy” 42
Troubleshooting fine-tuning procedures for qPCR system design 42
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples 41
Molecular Assessment in Patients with Melanoma: When and Why? 33
A NEXT GENERATION SEQUENCING APPROACH TO GENOMIC LANDSCAPE IN MELANOMA PATIENTS: EVOLUTION OF PATIENT-SPECIFIC RESPONSE TO THERAPY 33
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 32
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report 30
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 26
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 13
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab 9
Totale 3.596
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.908
article - articoli 16.570
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 178
Totale 33.656
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020274 0 0 0 0 0 41 58 28 41 55 42 9
2020/2021849 14 11 23 208 32 44 225 61 79 61 57 34
2021/2022554 73 11 17 44 23 34 11 144 17 69 16 95
2022/2023674 56 61 9 59 119 104 2 45 112 8 95 4
2023/2024385 10 47 14 48 24 59 14 41 20 17 10 81
2024/2025464 31 71 41 75 163 83 0 0 0 0 0 0
Totale 3.596